5 Papers
M. Ito is an academic researcher from Jikei University School of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases
M. Ito,Masahiro Kamata,Hideaki Uchida,Shota Egawa,Saki Fukaya,Kotaro Hayashi,Atsuko Fukuyasu,Takamitsu Tanaka,Takeko Ishikawa,Yayoi Tada +9 more
TL;DR: In this paper , the authors reported two patients with immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab, and attributed this phenomenon to the difference in elimination half-life of the two drugs and a slower onset of efficacy.
1
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in hemodialysis patients: A single-center retrospective study.
Hideaki Uchida,Masahiro Kamata,Takeko Ishikawa,M. Ito,Ayu Watanabe,Shota Egawa,Azusa Hiura,Saki Fukaya,Kotaro Hayashi,Atsuko Fukuyasu,Takamitsu Tanaka,Yayoi Tada +11 more
TL;DR: This study investigates the safety and effectiveness of fosravuconazole for onychomycosis in haemodialysis patients and shows efficacy and tolerable safety in patients excluded from the clinical trial due to safety concerns.
1
Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis
M. Ito,Masahiro Kamata,Takeko Ishikawa,Hideaki Uchida,Shoya Suzuki,Ryosuke Takeshima,Ayu Watanabe,Itsumi Mizukawa,Shota Egawa,Saki Fukaya,Kotaro Hayashi,Atsuko Fukuyasu,Takamitsu Tanaka,Yayoi Tada +13 more
TL;DR: In this article , the authors assessed the experience of atopic dermatitis (AD) patients treated with dupilumab before and after self-injection, utilizing the Self-Injection Assessment Questionnaire (SIAQ).
1
A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft
Koichi Yanaba,M. Ito,H. Sasaki,M. Inoue,Yoshimasa Nobeyama,H. Yonemoto,Takaoki Ishiji,H. Tanaka,Ryoichi Kamide,Michihito Niimura +9 more
TL;DR: Although the development of new lesions had ceased spontaneously, widespread ulceration of the skin remained, andbridement of the necrotic skin and skin grafting using cultured epidermal autografts and meshed allografteds of cadaver skin led to prompt reepithelization.
Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis
Hideaki Uchida,Masahiro Kamata,Ayu Watanabe,M. Ito,Saki Fukaya,Kotaro Hayashi,Atsuko Fukuyasu,Takamitsu Tanaka,Takeko Ishikawa,Yayoi Tada +9 more
- 23 Jul 2023
TL;DR: A patient with severe alopecia areata and atopic dermatitis showed significant improvement after 9-month baricitinib treatment, followed by upadacitinib use, highlighting potential therapeutic options for this challenging condition.